ConductScience.org, home

Paper3383205

Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon.

Guadagni F and 4 others. Cancer Immunol Immunother, 1988. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon. Papers, record 3383205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3383205

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1988
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
1.49
iCite
Revised in PubMed
2024-04-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guadagni FF
2Schlom JJ
3Pothen SS
4Pestka SS
5Greiner JWJ W

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adjuvants, ImmunologicMajor topic
Antibodies, MonoclonalMajor topic
CarcinomaMajor topic
Interferon Type IMajor topic
Recombinant ProteinsMajor topic
Animals
Binding Sites, Antibody
Breast Neoplasms
Cell Line
Colonic Neoplasms
Drug Administration Schedule
Female
Humans
Mice
Mice, Inbred BALB C
Mice, Nude
Neoplasm Transplantation

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12424575Modulation of antigen expression in human tumor cell populations.Cancer Invest1986https://conductscience.org/library/papers/2424575PubMed
23843352Modulation of tumor associated antigen expression and shedding by recombinant human leukocyte and fibroblast interferons.Pharmacol Ther1985https://conductscience.org/library/papers/3843352PubMed
36170263Antiproliferative and antiviral activities of human leukocyte interferons.Arch Biochem Biophys1981https://conductscience.org/library/papers/6170263PubMed
46176159Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.Ann Intern Med1982https://conductscience.org/library/papers/6176159PubMed
53160671Differential responsiveness of cloned mammary carcinoma cell populations to the human recombinant leukocyte interferon enhancement of tumor antigen expression.Int J Cancer1985https://conductscience.org/library/papers/3160671PubMed
63096562Enhancement by gamma-interferon of in vivo tumor radiolocalization by a monoclonal antibody against HLA-DR antigen.Cancer Res1986https://conductscience.org/library/papers/3096562PubMed
76622704Metastatic colon carcinoma detected with radiolabeled F(ab')2 monoclonal antibody fragments.Radiology1983https://conductscience.org/library/papers/6622704PubMed
86747299Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells.J Immunol1984https://conductscience.org/library/papers/6747299PubMed
925290651Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy.Immunol Today1981https://conductscience.org/library/papers/25290651PubMed
10719607Heterotransplantation of human cancers into nude mice: a model system for human cancer chemotherapy.Cancer1978https://conductscience.org/library/papers/719607PubMed
116744259Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment.Cancer Res1984https://conductscience.org/library/papers/6744259PubMed
123957460Use of monoclonal antibodies to human breast-tumor-associated antigens in fine-needle aspirate cytology.Int J Cancer1986https://conductscience.org/library/papers/3957460PubMed
132944575Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.Cancer Res1986https://conductscience.org/library/papers/2944575PubMed
145432063Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature1970https://conductscience.org/library/papers/5432063PubMed
153698030Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancer.Cancer Res1986https://conductscience.org/library/papers/3698030PubMed
163940648Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.Cancer Res1986https://conductscience.org/library/papers/3940648PubMed
176589637A species of human alpha interferon that lacks the ability to boost human natural killer activity.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6589637PubMed
186164056Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6164056PubMed
196159538Human leukocyte interferon produced by E. coli is biologically active.Nature1980https://conductscience.org/library/papers/6159538PubMed
203088107A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.J Immunol1986https://conductscience.org/library/papers/3088107PubMed

See all 39 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
27581603A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas.Cancer Immunol Immunother2016https://conductscience.org/library/papers/27581603PubMed
10459728Monoclonal antibody-directed cytotoxic therapy: potential in malignant diseases of aging.Drugs Aging1999https://conductscience.org/library/papers/10459728PubMed
2675955The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sites.Br J Cancer1989https://conductscience.org/library/papers/2675955PubMed
2248992Quantification of transport and binding parameters using fluorescence recovery after photobleaching. Potential for in vivo applications.Biophys J1990https://conductscience.org/library/papers/2248992PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNA23440PubTator's text mininghttps://conductscience.org/library/genes/3440

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3383205

GET https://conductscience.org/api/papers/v1/3383205/references?page=2